II. Background
- Phosphine (PH3) is released when metal phosphides such as aluminum come into contact with water
- Phosphine is used to manufacture semiconductors (Phosphorus introduced into silicon crystals)
- Other uses include fumigation, polymer synthesis, synthesis of flame retardants
- Also found in grain storage
- Solid phosphides may also release Phosphine Gas
- Phosphine is shipped as a liquefied and compressed gas
III. Mechanism: Toxicity
- Phosphine exposure may result in life-threatening toxicity
- Phosphine Toxicity directly affects alveolar capillary membranes
- Phosphines inhibit multiple enzymes that affect cell membranes
- Toxic dose
- Oral Lethal Doses
- Aluminum Phosphide: 500 mg
- Zinc Phosphoide: 4 grams
- Inhaled Gas toxicity
- Dangerous toxicity: 50 ppm
- Lethal exposure: 400 o 600 ppm (at <30 min of exposure)
- Oral Lethal Doses
IV. Symptoms
- Exposure occurs with inhalation, ingestion or transdermal contact
- Symptoms below follow inhalation and ingestion exposure
- Inhalation is primary exposure
- Phosphine Gas smells like Garlic or decaying fish (may be odorless)
- Odor is not sufficient warning to prevent Inhalation Injury
- Gastrointestinal
- Respiratory
- Airway Irritation
- Chest Tightness
- Shortness of Breath
- Respiratory distress
- Neurologic
- Headache
- Ataxia
- Numbness or Paresthesias
- Tremor
- Muscle Weakness
- Coma (severe exposure)
- Seizures (severe exposure)
- Cardiovascular (severe exposure)
- Hypotension or shock
- Dysrhythmias
- Congestive Heart Failure
- End organ injury (liver, Kidney)
V. Labs
- No clinically relevant test for Phosphine available
- Arterial Blood Gas or Venous Blood Gas
VI. Diagnostics
-
Electrocardiogram
- Evaluate for Dysfunction
-
Echocardiogram
- Evaluate for Left Ventricular Failure, dilitation or hypokinesis
VII. Imaging
-
Chest XRay
- May demonstrate infiltrates
VIII. Management
-
Decontamination
- See Decontamination
- Immediately remove from exposure
- Give charcoal 1 g/kg for ingestions
- Supportive care
- Advanced Airway as needed for acutre lung injury
- Intravenous Fluids and Vasopressors as needed for Hypotension
- Specific Management (experimental)
- N-Acetylcysteine
- Gastric Lavage
- Perform with Potassium permanganate (1:10,000) or Sodium Bicarbonate
- Disposition
- Observe for at least 24 hours for symptomatic inhalations or ingestions
- Observe for several hours if asymptomatic
IX. Resources
X. References
- Koch (2016) Crit Dec Emerg Med
- Sciuto (2016) Ann N Y Acad Sci 1374(1):41-51 +PMID: 27219283 [PubMed]